Key result
Mitral valve repair for active infective endocarditis demonstrated a hospital mortality of 11.6% and a 15-year overall survival of 57%.
Why the study?
Mitral valve repair rates in infective endocarditis remain low despite reported results in acute and healed endocarditis.
Cohort (n=160)
No
An early, repair-oriented surgical approach for mitral valve infective endocarditis demonstrates good long-term durability and freedom from reoperation.
Answers are grounded in this paper and cite their sources.
Supports MV repair feasibility in active IE at experienced centers; leaves open randomized comparisons versus replacement.
Many authors have reported their results of mitral valve (MV) repair (MVr) in acute and healed endocarditis. However, the results published by different authors highlight the fact that the reparability rate for this indication remains low. Over the last three decades, our group has adopted an early and repair-oriented approach to infective endocarditis with the objective to improve the repair rate and the long-term results. In this paper, we describe our institutional experience on mitral valve repair for infective endocarditis. Data for this paper were extracted from our institutional database on heart valve disease. From 1991 to 2015, 160 consecutive patients in our institution underwent MV surgery for active IE on native MV. The median follow-up was 122 months. This study was approved by the institutional ethics review board, and written informed consent was waived for this study given its retrospective design. Hospital mortality was 11.6% (n = 18). Early MV reoperation before hospital discharge was required in five (3.1%) patients. At 5, 10, and 15 years, overall survival in the MVr for endocarditis in the group was 79% ± 4%, 65% ± 5%, 57% ± 6%, respectively. Freedom from reoperation at 5, 10, and 15 years was 95% ± 2%, 88% ± 4%, and 81% ± 6%, respectively. Mitral infective endocarditis is an insidious pathology and his surgical approach can be challenging. An early and repair-oriented surgical approach can allow to improve reparability rates with good long-term durability and a low recurrence rate of endocarditis.
No takes yet. Share an insight, caveat, or question.
Solari et al. (2021) conducted a cohort in Active infective endocarditis on native mitral valve (n=160). Mitral valve repair was evaluated on Hospital mortality. Mitral valve repair for active infective endocarditis demonstrated a hospital mortality of 11.6% and a 15-year overall survival of 57%.
Synapse has enriched 10 related papers. Consider them for comparative context: